Impact of Bifurcation Lesions on Outcomes After FFR-Guided PCI or CABG

Overview

Journal Circ Cardiovasc Interv

Specialty Cardiology & Vascular Diseases

Date 2024 Dec 27

PMID 39727036

Authors

Daimy M M Dillen

Hisao Otsuki

Kuniaki Takahashi

Yuhei Kobayashi

Zsolt Piroth

Nicolas Noiseux

Badih El Nakadi

Gintaras Kalinauskas

Laszlo Szekely

Giedrius Davidavicius

Koen Teeuwen

Pim A L Tonino

Nico H J Pijls

Bernard De Bruyne

William F Fearon

Frederik M Zimmermann

Affiliations

Soon will be listed here.

Abstract

Background: In the era of first-generation drug-eluting stents and angiography-guided percutaneous coronary intervention (PCI), the presence of a bifurcation lesion was associated with adverse outcomes after PCI. In contrast, the presence of a bifurcation lesion had no impact on outcomes following coronary artery bypass grafting (CABG). Therefore, the presence of a coronary bifurcation lesion requires special attention when choosing between CABG and PCI. The aim of this study is to assess whether the presence of a bifurcation lesion still influences clinical outcomes after contemporary PCI using second-generation drug-eluting stent and fractional flow reserve (FFR) guidance versus CABG.

Methods: The randomized FAME 3 trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) compared FFR-guided PCI using current drug-eluting stents with CABG in patients with 3-vessel coronary artery disease. The prespecified key end point at 3-year follow-up was the composite of death, myocardial infarction, or stroke. In this substudy, the impact of bifurcation lesions on outcomes after FFR-guided PCI and CABG was investigated.

Results: The FAME 3 trial enrolled 1500 patients and 653 (45.2%) patients had at least 1 true bifurcation lesion. There was no difference in the composite of death, myocardial infarction, or stroke at the 3-year follow-up between patients with or without at least 1 true bifurcation lesion (11.6% versus 10.0%; hazard ratio, 1.17 [95% CI, 0.86-1.61]; =0.32), regardless of revascularization strategy. The composite end point was not statistically different between FFR-guided PCI and CABG in patients with at least 1 true bifurcation lesion (hazard ratio, 1.27 [95% CI, 0.80-2.00]) or without a true bifurcation lesion (hazard ratio, 1.36 [95% CI, 0.87-2.12]), with no significant interaction (=0.81).

Conclusions: In patients with 3-vessel coronary artery disease, the presence of a true bifurcation lesion was not associated with a different treatment effect after FFR-guided PCI with contemporary drug-eluting stent versus CABG.

References

Costopoulos C, Latib A, Ferrarello S, Naganuma T, Sticchi A, Filippo F . First- versus second-generation drug-eluting stents for the treatment of coronary bifurcations. Cardiovasc Revasc Med. 2013; 14(6):311-5. DOI: 10.1016/j.carrev.2013.09.006. View

Modolo R, Kogame N, Komiyama H, Chichareon P, de Vries T, Tomaniak M . Two years clinical outcomes with the state-of-the-art PCI for the treatment of bifurcation lesions: A sub-analysis of the SYNTAX II study. Catheter Cardiovasc Interv. 2019; 96(1):10-17. DOI: 10.1002/ccd.28422. View

Hildick-Smith D, Egred M, Banning A, Brunel P, Ferenc M, Hovasse T . The European bifurcation club Left Main Coronary Stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN). Eur Heart J. 2021; 42(37):3829-3839. DOI: 10.1093/eurheartj/ehab283. View

Neumann F, Sousa-Uva M, Ahlsson A, Alfonso F, Banning A, Benedetto U . 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2018; 40(2):87-165. DOI: 10.1093/eurheartj/ehy394. View

Levine G, Bates E, Blankenship J, Bailey S, Bittl J, Cercek B . 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and.... Circulation. 2011; 124(23):e574-651. DOI: 10.1161/CIR.0b013e31823ba622. View

Zimmermann F, Ding V, Pijls N, Piroth Z, van Straten A, Szekely L . Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial. Circulation. 2023; 148(12):950-958. DOI: 10.1161/CIRCULATIONAHA.123.065770. View

Lee J, Hahn J, Kang J, Park K, Chun W, Rha S . Differential Prognostic Effect Between First- and Second-Generation Drug-Eluting Stents in Coronary Bifurcation Lesions: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts. JACC Cardiovasc Interv. 2015; 8(10):1318-1331. DOI: 10.1016/j.jcin.2015.05.014. View

Madhavan M, Kirtane A, Redfors B, Genereux P, Ben-Yehuda O, Palmerini T . Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention. J Am Coll Cardiol. 2020; 75(6):590-604. DOI: 10.1016/j.jacc.2019.11.058. View

Choi K, Song Y, Lee J, Park T, Yang J, Hahn J . Differential Long-Term Effects of First- and Second-Generation DES in Patients With Bifurcation Lesions Undergoing PCI. JACC Asia. 2022; 1(1):68-79. PMC: 9627880. DOI: 10.1016/j.jacasi.2021.04.006. View

10.

Zimmermann F, De Bruyne B, Pijls N, Desai M, Oldroyd K, Park S . Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients.... Am Heart J. 2015; 170(4):619-626.e2. DOI: 10.1016/j.ahj.2015.06.024. View

11.

Chen S, Ye F, Zhang J, Xu T, Tian N, Liu Z . Randomized Comparison of FFR-Guided and Angiography-Guided Provisional Stenting of True Coronary Bifurcation Lesions: The DKCRUSH-VI Trial (Double Kissing Crush Versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions VI). JACC Cardiovasc Interv. 2015; 8(4):536-46. DOI: 10.1016/j.jcin.2014.12.221. View

12.

Holm N, Andreasen L, Neghabat O, Laanmets P, Kumsars I, Bennett J . OCT or Angiography Guidance for PCI in Complex Bifurcation Lesions. N Engl J Med. 2023; 389(16):1477-1487. DOI: 10.1056/NEJMoa2307770. View

13.

Serruys P, Morice M, Kappetein A, Colombo A, Holmes D, Mack M . Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009; 360(10):961-72. DOI: 10.1056/NEJMoa0804626. View

14.

Fearon W, Zimmermann F, De Bruyne B, Piroth Z, van Straten A, Szekely L . Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery. N Engl J Med. 2021; 386(2):128-137. DOI: 10.1056/NEJMoa2112299. View

15.

Arunothayaraj S, Behan M, Lefevre T, Lassen J, Chieffo A, Stankovic G . Stepwise provisional versus systematic culotte for stenting of true coronary bifurcation lesions: five-year follow-up of the multicentre randomised EBC TWO Trial. EuroIntervention. 2023; . PMC: 10333921. DOI: 10.4244/EIJ-D-23-00211. View

16.

Ninomiya K, Serruys P, Garg S, Gao C, Masuda S, Lunardi M . Predicted and Observed Mortality at 10 Years in Patients With Bifurcation Lesions in the SYNTAX Trial. JACC Cardiovasc Interv. 2022; 15(12):1231-1242. DOI: 10.1016/j.jcin.2022.04.025. View